Robert Wild to Hydroxymethylglutaryl-CoA Reductase Inhibitors
This is a "connection" page, showing publications Robert Wild has written about Hydroxymethylglutaryl-CoA Reductase Inhibitors.
Connection Strength
1.026
-
The risks of statin use in pregnancy: A systematic review. J Clin Lipidol. 2016 Sep-Oct; 10(5):1081-90.
Score: 0.482
-
Baseline use of aspirin or statins with oral estrogen and progestogens to prevent incident arterial or venous thrombotic events: a secondary analysis of the Women's Health Initiative trial. Menopause. 2026 Feb 01; 33(2):134-144.
Score: 0.234
-
Lipids and Women's Health: Recent Updates and Implications for Practice. J Womens Health (Larchmt). 2019 06; 28(6):752-760.
Score: 0.138
-
Gender differences in side effects and attitudes regarding statin use in the Understanding Statin Use in America and Gaps in Patient Education (USAGE) study. J Clin Lipidol. 2016 Jul-Aug; 10(4):833-841.
Score: 0.118
-
National lipid association recommendations for patient-centered management of dyslipidemia: part 1--full report. J Clin Lipidol. 2015 Mar-Apr; 9(2):129-69.
Score: 0.028
-
National Lipid Association recommendations for patient-centered management of dyslipidemia: part 1 - executive summary. J Clin Lipidol. 2014 Sep-Oct; 8(5):473-88.
Score: 0.026